During the past decade, Rocky Mountain Retina Consultants conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 5 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 3 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Rocky Mountain Retina Consultants" #1 sponsor was "Hoffmann-La Roche" with 8 trials, followed by "Genentech, Inc." with 3 trials sponsored, "Jaeb Center for Health Research" with 2 trials sponsored, "Allergan" with 1 trials sponsored and "Clearside Biomedical, Inc." with 1 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Rocky Mountain Retina Consultants" #1 collaborator was "National Eye Institute (NEI)" with 2 trials as a collaborator, "Allergan" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator and "Novartis Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Rocky Mountain Retina Consultants" are "Diabetic Macular Edema" (5 trials), "Macular Degeneration" (5 trials), "Diabetic Retinopathy" (3 trials), "Exudative Age-related Macular Degeneration" (2 trials) and "Geographic Atrophy" (2 trials). Many other conditions were trialed in "Rocky Mountain Retina Consultants" in a lesser frequency.

Most popular intervention types in "Rocky Mountain Retina Consultants" are "Drug" (19 trials), "Other" (4 trials), "Procedure" (3 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Ranibizumab" (3 trials), "Sham Procedure" (3 trials), "Aflibercept" (2 trials), "Faricimab" (2 trials) and "Intravitreal Ranibizumab 0.5 mg Injection" (2 trials). Other intervention names were less common.

The vast majority of trials in "Rocky Mountain Retina Consultants" are 23 trials for "All" genders.

Currently, there are NaN active trials in "Rocky Mountain Retina Consultants". undefined are not yet recruiting, 3 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Rocky Mountain Retina Consultants, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Rocky Mountain Retina Consultants, 1 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".